154 related articles for article (PubMed ID: 29658620)
1. Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran.
Kheirandish M; Varahrami V; Kebriaeezade A; Cheraghali AM
East Mediterr Health J; 2018 Apr; 24(1):42-51. PubMed ID: 29658620
[TBL] [Abstract][Full Text] [Related]
2. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.
Setayesh S; Mackey TK
Global Health; 2016 Jun; 12(1):31. PubMed ID: 27267898
[TBL] [Abstract][Full Text] [Related]
3. Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector.
Emami F; Cheraghali AM
Res Pharm Sci; 2022 Jun; 17(3):274-283. PubMed ID: 35531135
[TBL] [Abstract][Full Text] [Related]
4. Policies to improve access to pharmaceutical products in shortage: the experience of Iran food and drug administration.
Yousefi N; Moradi N; Dinarvand R; Ghiasi G; Inanloo H; Peiravian F
Daru; 2019 Jun; 27(1):169-177. PubMed ID: 30903556
[TBL] [Abstract][Full Text] [Related]
5. The Impact of the Sanctions Made Against Iran on Availability to Asthma Medicines in Tehran.
Ghiasi G; Rashidian A; Kebriaeezadeh A; Salamzadeh J
Iran J Pharm Res; 2016; 15(3):567-571. PubMed ID: 27980593
[TBL] [Abstract][Full Text] [Related]
6. Economic sanctions threaten population health: the case of Iran.
Aloosh M; Salavati A; Aloosh A
Public Health; 2019 Apr; 169():10-13. PubMed ID: 30771721
[TBL] [Abstract][Full Text] [Related]
7. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya.
Wirtz VJ; Turpin K; Laing RO; Mukiira CK; Rockers PC
Trop Med Int Health; 2018 Aug; 23(8):879-885. PubMed ID: 29808960
[TBL] [Abstract][Full Text] [Related]
8. Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.
Bastani P; Dehghan Z; Kashfi SM; Dorosti H; Mohammadpour M; Mehralian G
Iran J Med Sci; 2022 Mar; 47(2):152-161. PubMed ID: 35291429
[TBL] [Abstract][Full Text] [Related]
9. Iran, sanctions, and the COVID-19 crisis.
Abdoli A
J Med Econ; 2020 Dec; 23(12):1461-1465. PubMed ID: 33249954
[TBL] [Abstract][Full Text] [Related]
10. The impact of international economic sanctions on Iranian cancer healthcare.
Shahabi S; Fazlalizadeh H; Stedman J; Chuang L; Shariftabrizi A; Ram R
Health Policy; 2015 Oct; 119(10):1309-18. PubMed ID: 26344426
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.
Kokabisaghi F
Int J Health Policy Manag; 2018 May; 7(5):374-393. PubMed ID: 29764102
[TBL] [Abstract][Full Text] [Related]
12. Impacts of international sanctions on Iranian pharmaceutical market.
Cheraghali AM
Daru; 2013 Jul; 21(1):64. PubMed ID: 23902642
[TBL] [Abstract][Full Text] [Related]
13. A news media analysis of economic sanction effects on access to medicine in Iran.
Kheirandish M; Rashidian A; Bigdeli M
J Res Pharm Pract; 2015; 4(4):199-205. PubMed ID: 26645026
[TBL] [Abstract][Full Text] [Related]
14. Using the fuzzy logic approach to extract the index of economic sanctions in the Islamic Republic of Iran.
Iranmanesh S; Salehi N; Jalaee SA
MethodsX; 2021; 8():101301. PubMed ID: 34434821
[TBL] [Abstract][Full Text] [Related]
15. Availability, Price, and Affordability of Essential Medicines to Manage Noncommunicable Diseases: A National Survey From Nepal.
Khanal S; Veerman L; Ewen M; Nissen L; Hollingworth S
Inquiry; 2019; 56():46958019887572. PubMed ID: 31823665
[TBL] [Abstract][Full Text] [Related]
16. The development of the noncommunicable diseases emergency health kit.
Slama S; Lee J; Aragno M; Laroche S; Hogerzeil H
East Mediterr Health J; 2018 Apr; 24(1):92-98. PubMed ID: 29658625
[TBL] [Abstract][Full Text] [Related]
17. Effects of the international economic sanctions on access to medicine of the Iranian people: A systematic review.
Asadi-Pooya AA; Nazari M; Damabi NM
J Clin Pharm Ther; 2022 Dec; 47(12):1945-1951. PubMed ID: 36401156
[TBL] [Abstract][Full Text] [Related]
18. Perceptions of Kenyan adults on access to medicines for non-communicable diseases: A qualitative study.
Onyango MA; Vian T; Hirsch I; Salvi DD; Laing R; Rockers PC; Ashigbie PG; Wirtz VJ
PLoS One; 2018; 13(8):e0201917. PubMed ID: 30142218
[TBL] [Abstract][Full Text] [Related]
19. The human cost of economic sanctions and strategies for building health system resilience: A scoping review of studies in Iran.
Sajadi HS; Yahyaei F; Ehsani-Chimeh E; Majdzadeh R
Int J Health Plann Manage; 2023 Sep; 38(5):1142-1160. PubMed ID: 37194133
[TBL] [Abstract][Full Text] [Related]
20. Trends in cost and consumption of essential medicines for non-communicable diseases in Azerbaijan, Georgia, and Uzbekistan, from 2019 to 2021.
Kadyrova N; Gotham D; Kniazkov S; Aghayev E; Hajibalayev P; Ermatov Z; Azzopardi Muscat N
PLoS One; 2023; 18(12):e0294680. PubMed ID: 38060531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
